Total Liabilities - Maat Pharma SA (PAR:MAAT) - Alpha Spread
M

Maat Pharma SA
PAR:MAAT

Watchlist Manager
Maat Pharma SA
PAR:MAAT
Watchlist
Price: 7.3 EUR 2.24% Market Closed
Market Cap: 101.4m EUR
Have any thoughts about
Maat Pharma SA?
Write Note

Maat Pharma SA
Total Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Maat Pharma SA
Total Liabilities Peer Comparison

Comparables:
VLA
NANO
IPH
GNFT
ALERS

Competitive Total Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
M
Maat Pharma SA
PAR:MAAT
Total Liabilities
€22.5m
CAGR 3-Years
39%
CAGR 5-Years
37%
CAGR 10-Years
N/A
Valneva SE
PAR:VLA
Total Liabilities
€300.3m
CAGR 3-Years
-23%
CAGR 5-Years
21%
CAGR 10-Years
11%
Nanobiotix SA
PAR:NANO
Total Liabilities
€95.7m
CAGR 3-Years
15%
CAGR 5-Years
25%
CAGR 10-Years
37%
Innate Pharma SA
PAR:IPH
Total Liabilities
€122.7m
CAGR 3-Years
-3%
CAGR 5-Years
-6%
CAGR 10-Years
21%
Genfit SA
NASDAQ:GNFT
Total Liabilities
€105.9m
CAGR 3-Years
-21%
CAGR 5-Years
-13%
CAGR 10-Years
22%
Eurobio Scientific SA
PAR:ALERS
Total Liabilities
€141.3m
CAGR 3-Years
29%
CAGR 5-Years
28%
CAGR 10-Years
26%

See Also

What is Maat Pharma SA's Total Liabilities?
Total Liabilities
22.5m EUR

Based on the financial report for Dec 31, 2023, Maat Pharma SA's Total Liabilities amounts to 22.5m EUR.

What is Maat Pharma SA's Total Liabilities growth rate?
Total Liabilities CAGR 5Y
37%

Over the last year, the Total Liabilities growth was 25%. The average annual Total Liabilities growth rates for Maat Pharma SA have been 39% over the past three years , 37% over the past five years .

Back to Top